Neogenomics, Inc.
NEO
$16.21
$0.372.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 113.08% | -73.12% | 63.58% | 39.84% | -73.95% |
| Total Depreciation and Amortization | 0.73% | 0.11% | -0.26% | -4.83% | -2.58% |
| Total Amortization of Deferred Charges | -- | -- | 0.52% | -69.10% | -- |
| Total Other Non-Cash Items | -115.96% | 16.58% | -48.07% | -40.98% | 150.99% |
| Change in Net Operating Assets | 111.94% | -22.77% | -6,820.35% | -101.61% | 146.34% |
| Cash from Operations | 345.29% | -705.88% | -84.88% | -56.30% | 180.27% |
| Capital Expenditure | -64.38% | 36.48% | 5.33% | -31.49% | -40.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 92.27% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -105.88% | 183.33% | -62.78% |
| Cash from Investing | -66.38% | 20.70% | -2,176.17% | 97.03% | -361.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -18.83% | -61.83% | 46.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8,282.25% | -- | -- | -- | -- |
| Cash from Financing | -3,522.49% | -178.42% | -43.66% | 100.38% | -21,431.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 45.45% | 140.74% | -- |
| Net Change in Cash | 95.52% | -199.51% | -147.89% | 104.91% | -819.74% |